Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kala Pharmaceuticals Inc.

    NASDAQ: KALA · Real-Time Price · USD
    8.19
    -0.20 (-2.38%)
    At close: Aug 20, 2025, 10:09 AM

    Kala Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 3.89M 11.24M
    Cost of Revenue
    		 259K 303K 2.56M 4.1M
    Gross Profit
    		 -259K -303K 1.33M 7.14M
    Operating Income
    		 -40.98M -39.15M -81.36M -109.43M
    Interest Income
    		 2.06M 2.71M 664K 104K
    Pretax Income
    		 -38.51M -42.2M -44.82M -142.6M
    Net Income
    		 -38.51M -42.2M -44.82M -142.6M
    Selling & General & Admin
    		 18.34M 20.26M 65.03M 105.06M
    Research & Development
    		 22.09M 18.59M 17.65M 11.52M
    Other Expenses
    		 -259K n/a n/a n/a
    Operating Expenses
    		 40.17M 38.85M 82.69M 116.58M
    Interest Expense
    		 5.78M 5.81M 7.27M 8.38M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 40.98M 39.15M 85.25M 120.67M
    Income Tax Expense
    		 n/a n/a -44.6M 9.69M
    Shares Outstanding (Basic)
    		 5.52M 2.43M 1.52M 1.3M
    Shares Outstanding (Diluted)
    		 5.52M 2.43M 1.52M 1.3M
    EPS (Basic)
    		 -6.98 -17.35 -29.48 -109.35
    EPS (Diluted)
    		 -6.98 -17.35 -29.48 -109.35
    EBITDA
    		 -40.98M -36.08M -36.7M -131.96M
    EBIT
    		 -44.29M -36.38M -37.56M -134.22M
    Depreciation & Amortization
    		 3.31M 303K 860K 2.27M

    Add to Watchlist